Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled date : 2021 - 06 - 11 save search
Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine
Published: 2021-06-11 (Crawled : 21:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
| Email alert
Add to watchlist
covid positive vaccine
EHA Updates: Companies Share Positive Data in Different Blood Disorders
Published: 2021-06-11 (Crawled : 18:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -0.09%
EQ | $1.77 -1.12% -1.13% 74K
|
Health Technology
|
| O: -6.16%
H: 0.31%
C: -6.41%
blood positive
Hycroft Management And Existing Shareholders Increase Positions In Hycroft
Published: 2021-06-11 (Crawled : 16:00) - prnewswire.com
HYMC | $3.58 -3.24% -3.35% 350K
|
Non-Energy Minerals
|
| O: 3.3%
H: 5.85%
C: -2.93%
positive
BeiGene Presents Positive Data in Various Lymphomas at EHA2021
Published: 2021-06-11 (Crawled : 15:15) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.01%
H: 0.01%
C: -1.26%
positive presentation
Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease
Published: 2021-06-11 (Crawled : 12:00) - biospace.com/
EQ | $1.77 -1.12% -1.13% 74K
|
Health Technology
|
| O: -6.16%
H: 0.31%
C: -6.41%
disease treatment positive results topline
Curis Announces Positive Updated Data from Ongoing Phase 1/2 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes
Published: 2021-06-11 (Crawled : 12:00) - biospace.com/
CRIS | $14.96 -6.21% -6.62% 20K
|
Health Technology
|
| O: -23.82%
H: 0.41%
C: -17.08%
myeloid leukemia ongoing phase 1 positive therapy leukemia phase 3 phase 2 syndros ca-4948 acute myeloid leukemia
Novan Reports Positive Topline Results from Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum
Published: 2021-06-11 (Crawled : 11:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 58.85%
H: 30.08%
C: 2.23%
molluscum positive results topline phase 3 trial
X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia at EHA 2021
Published: 2021-06-11 (Crawled : 08:00) - globenewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.0%
H: 0.1%
C: -0.71%
XFOR | $1.195 0.0% 1.7M
|
Health Technology
|
| O: -1.8%
H: 0.97%
C: -5.51%
presentation ongoing phase 1 positive trial phase 1b phase 2b
Agios Presents Positive Results from Phase 2 Study of Mitapivat in Non-transfusion-dependent α- and β-Thalassemia at the European Hematology Association Virtual Congress
Published: 2021-06-11 (Crawled : 08:00) - globenewswire.com
AGIO | News | $29.43 1.38% 1.36% 550K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: -3.51%
phase 2 positive results europe positive results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.